113 related articles for article (PubMed ID: 31520191)
21. Construction of pH-sensitive lysozyme/pectin nanogel for tumor methotrexate delivery.
Lin L; Xu W; Liang H; He L; Liu S; Li Y; Li B; Chen Y
Colloids Surf B Biointerfaces; 2015 Feb; 126():459-66. PubMed ID: 25601095
[TBL] [Abstract][Full Text] [Related]
22. [Fundamental studies on locally injected methotrexate bound to activated carbon particles (MTX-CH)].
Fujiyama J; Nakase Y; Mochizuki S; Togawa T; Suzuki G; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1844-6. PubMed ID: 15553734
[TBL] [Abstract][Full Text] [Related]
23. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
24. A micelle-like structure of poloxamer-methotrexate conjugates as nanocarrier for methotrexate delivery.
Ren J; Fang Z; Yao L; Dahmani FZ; Yin L; Zhou J; Yao J
Int J Pharm; 2015 Jun; 487(1-2):177-86. PubMed ID: 25865570
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
26. Inorganic nanovehicle targets tumor in an orthotopic breast cancer model.
Choi G; Kwon OJ; Oh Y; Yun CO; Choy JH
Sci Rep; 2014 Mar; 4():4430. PubMed ID: 24651154
[TBL] [Abstract][Full Text] [Related]
27. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
[TBL] [Abstract][Full Text] [Related]
28. Application of anti-methotrexate Fab fragments for the optimization of intraperitoneal methotrexate therapy in a murine model of peritoneal cancer.
Lobo ED; Balthasar JP
J Pharm Sci; 2005 Sep; 94(9):1957-64. PubMed ID: 16052545
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate-grafted-oligochitosan micelles as drug carriers: synthesis and biological evaluations.
Fattahi A; Asgarshamsi M; Hasanzadeh F; Varshosaz J; Rostami M; Mirian M; Sadeghi-aliabadi H
J Mater Sci Mater Med; 2015 Feb; 26(2):119. PubMed ID: 25677115
[TBL] [Abstract][Full Text] [Related]
30. A novel platform designed by Au core/inorganic shell structure conjugated onto MTX/LDH for chemo-photothermal therapy.
Tian DY; Wang WY; Li SP; Li XD; Sha ZL
Int J Pharm; 2016 May; 505(1-2):96-106. PubMed ID: 26997424
[TBL] [Abstract][Full Text] [Related]
31. Curcumin ameliorates the targeted delivery of methotrexate intercalated montmorillonite clay to cancer cells.
Kar S; Kundu B; Reis RL; Sarkar R; Nandy P; Basu R; Das S
Eur J Pharm Sci; 2019 Jul; 135():91-102. PubMed ID: 31078644
[TBL] [Abstract][Full Text] [Related]
32. Induction of Au-methotrexate conjugates by sugar molecules: production, assembly mechanism, and bioassay studies.
Wang WY; Zhao XF; Ju XH; Liu P; Li J; Tang YW; Li SP; Li XD; Song FG
Int J Pharm; 2018 Mar; 538(1-2):65-78. PubMed ID: 29341908
[TBL] [Abstract][Full Text] [Related]
33. [Usefulness of local administration of methotrexate bound to activated carbon particles (MTX-CH)].
Ito T; Takagi T; Shimomura K; Takemura M; Toma A; Fujiyama J; Sonoyama Y; Sakakura C; Ootsuji E; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1696-8. PubMed ID: 11708012
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of a biocompatible gelatin functionalized graphene nanosheets and its application for drug delivery.
An J; Gou Y; Yang C; Hu F; Wang C
Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):2827-37. PubMed ID: 23623103
[TBL] [Abstract][Full Text] [Related]
35. Microemulsions for Colorectal Cancer Treatments. General Considerations and Formulation of Methotrexate.
Flores SE; Rial-Hermida MI; Ramirez JC; Pazos A; Concheiro A; Alvarez-Lorenzo C; Peralta RD
Mini Rev Med Chem; 2016; 16(6):498-508. PubMed ID: 26349496
[TBL] [Abstract][Full Text] [Related]
36. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
Salehi R; Rasouli S; Hamishehkar H
Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
[TBL] [Abstract][Full Text] [Related]
37. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition.
Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate loaded self stabilized calcium phosphate nanoparticles: a novel inorganic carrier for intracellular drug delivery.
Mukesh U; Kulkarni V; Tushar R; Murthy RS
J Biomed Nanotechnol; 2009 Feb; 5(1):99-105. PubMed ID: 20055112
[TBL] [Abstract][Full Text] [Related]
39. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of sandwich-like mesoporous silica nanoflakes as promising anticancer drug delivery system.
Peruzynska M; Szelag S; Trzeciak K; Kurzawski M; Cendrowski K; Barylak M; Roginska D; Piotrowska K; Mijowska E; Drozdzik M
Int J Pharm; 2016 Jun; 506(1-2):458-68. PubMed ID: 27032563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
